Jonathan Lao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jonathan Lao has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Crispin
Institute of Medical Information Processing, Biometry and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Marchioninistraße 15, 81377 Munich, Germany
1 shared publication - Antonio Jesus Salinas
Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense de Madrid, UCM, Instituto de Investigación Hospital 12 de Octubre, Imas12, 28040 Madrid, Spain
1 shared publication - Boris Michael Holzapfel
Department of Orthopaedics and Trauma Surgery, Musculoskeletal University Center Munich (MUM), University Hospital, LMU Munich, Munich, Germany
1 shared publication - Christine Taviot-Guého
Institut de Chimie de Clermont-Ferrand, Université Clermont Auvergne, UMR CNRS 6296, Clermont Auvergne INP, 24 av Blaise Pascal, BP 80026, 63171 Aubière cedex, France
1 shared publication - Cédric Bossard
Laboratoire de Physique de Clermont (LPC), Université Clermont Auvergne, CNRS/IN2P3, F-63000 Clermont-Ferrand, France
1 shared publication - Edouard Jallot
Laboratoire de Physique de Clermont (LPC), Université Clermont Auvergne, CNRS/IN2P3, F-63000 Clermont-Ferrand, France
1 shared publication
Latest Publications
- Open Access
Zinc-Doped Bioactive Glass/Polycaprolactone Hybrid Scaffolds Manufactured by Direct and Indirect 3D Printing Methods for Bone Regeneration
A novel organic–inorganic hybrid, based on SiO2-CaO-ZnO bioactive glass (BG) and polycaprolactone (PCL), associating the highly bioactive and versatile bioactive glass with clinically established PCL was examined. The BG–PCL hybrid is obtained by acid-catalyzed silica sol–gel process inside PCL solution either by direct or indirect printing. Apatite-formation tests in simulated body fluid (SBF) confirm the ion release along with the hybrid’s bone-like apatite forming. Kinetics differ significantly between directly and indirectly printed scaffolds, the former requiring longer periods to degrade, while the latter demonstrates faster calcium phosphate (CaP) formation. Remarkably, Zn diffusion and accumulation are observed at the surface within the newly formed active CaP layer. Zn release is found to be dependent on printing method and immersion medium. Investigation of BG at the atomic scale reveals the ambivalent role of Zn, capable of acting both as a network modifier and as a network former linking the BG silicate network. In addition, hMSCs viability assay proves no cytotoxicity of the Zn hybrid. LIVE/DEAD staining demonstrated excellent cell viability and proliferation for over seven weeks. Overall, this hybrid material either non-doped or doped with a metal trace element is a promising candidate to be translated to clinical applications for bone regeneration.
Open AccessZinc-Doped Bioactive Glass/Polycaprolactone Hybrid Scaffolds Manufactured by Direct and Indirect 3D Printing Methods for Bone Regeneration
A novel organic–inorganic hybrid, based on SiO2-CaO-ZnO bioactive glass (BG) and polycaprolactone (PCL), associating the highly bioactive and versatile bioactive glass with clinically established PCL was examined. The BG–PCL hybrid is obtained by acid-catalyzed silica sol–gel process inside PCL solution either by direct or indirect printing. Apatite-formation tests in simulated body fluid (SBF) confirm the ion release along with the hybrid’s bone-like apatite forming. Kinetics differ significantly between directly and indirectly printed scaffolds, the former requiring longer periods to degrade, while the latter demonstrates faster calcium phosphate (CaP) formation. Remarkably, Zn diffusion and accumulation are observed at the surface within the newly formed active CaP layer. Zn release is found to be dependent on printing method and immersion medium. Investigation of BG at the atomic scale reveals the ambivalent role of Zn, capable of acting both as a network modifier and as a network former linking the BG silicate network. In addition, hMSCs viability assay proves no cytotoxicity of the Zn hybrid. LIVE/DEAD staining demonstrated excellent cell viability and proliferation for over seven weeks. Overall, this hybrid material either non-doped or doped with a metal trace element is a promising candidate to be translated to clinical applications for bone regeneration.
- Open Access
- 17 August 2021
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 9
Editorial: Hybrids Part A: Hybrids for Tissue Regeneration
Editorial: Hybrids Part A: Hybrids for Tissue Regeneration
- 17 August 2021
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 9
Open AccessEditorial: Hybrids Part A: Hybrids for Tissue Regeneration
Editorial: Hybrids Part A: Hybrids for Tissue Regeneration